A simple, feasible, efficient and safe treatment strategy of sofosbuvir/velpatasvir for chronic HCV/HIV-1 coinfected patients regardless of HCV genotypes: a multicenter, open-label study in China
2023 · The Lancet Regional Health - Western Pacific · 5 citations
https://doi.org/10.1016/j.lanwpc.2023.100749